In the last trading session, 2.96 million Verve Therapeutics Inc (NASDAQ:VERV) shares changed hands as the company’s beta touched 1.66. With the company’s per share price at $4.63 changed hands at $0.31 or 7.18% during last session, the market valuation stood at $412.73M. VERV’s last price was a discount, traded about -101.08% off its 52-week high of $9.31. The share price had its 52-week low at $2.86, which suggests the last value was 38.23% up since then.
Analysts gave the Verve Therapeutics Inc (VERV) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended VERV as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight.
Verve Therapeutics Inc (NASDAQ:VERV) trade information
Instantly VERV was in green as seen at the end of in last trading. With action 9.46%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -17.91%, with the 5-day performance at 9.46% in the green. However, in the 30-day time frame, Verve Therapeutics Inc (NASDAQ:VERV) is 2.66% up.
The consensus price target for the stock as assigned by Wall Street analysts is 15, meaning bulls need an upside of 69.13% from its current market value. According to analyst projections, VERV’s forecast low is 15 with 15 as the target high. To hit the forecast high, the stock’s price needs a -223.97% plunge from its current level, while the stock would need to soar -223.97% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -42.43%. The 2025 estimates are for Verve Therapeutics Inc earnings to decrease by -1.90%, but the outlook for the next 5-year period is at 0.40% per year.
VERV Dividends
Verve Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.8598% or 6.62 million shares worth $32.31 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.13 shares estimated at $9.87 million under it, the former controlled 2.39% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.09% of the shares, roughly 1.87 shares worth around $8.65 million.
